DLeader
AI Agents · Drug Discovery
Overview
KumiChem is DLeader's agentic AI platform for RNA drug discovery — ASO and siRNA design, in silico toxicity screening, and data-driven candidate prioritization, from a simple prompt to a validated candidate.
Funding and backers
Backers
1
Techstars
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We believe every clinical trial should be run twice — first in silico. InSilicoTrials · Est.
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Regor combines a cutting-edge drug discovery engine with target validation and optimization for preclinical candidates in metabolism…
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
In silico phenotypic screening. Structure-based tools miss cellular context and off-target effects. Reflector Bio predicts how your…
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
TechstarsVia a fund
4363 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Osaka
Japan
HQ
DLeader Inc
12-12, Osaka Ekimae No. 2 Building, 2-2